Litcius/Paper detail

Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina

Ricardo Alonso, Magdalena Casas, Luciana Lazaro, Nora Fernández Liguori, Cecilia Pita, Leila Cohen, Juan Ignacio Rojas, Agustín Pappolla, Liliana Patrucco, Edgardo Cristiano, Marcos Burgos, Cárlos Vrech, Raúl Piedrabuena, Pablo A. López, Norma Deri, Geraldine Luetic, Jimena Míguez, Mariela Cabrera, Alejandra Martínez, Gisela Zanga, Verónica Tkachuk, Santiago Tizio, Edgar Carnero Contentti, Eduardo Knorre, Felisa Leguizamón, Carolina Mainella, Pedro Nofal, Susana Liwacki, Javier Hryb, María Laura Menichini, Claudia Pestchanker, Orlando Garcea, Berenice Silva

2023Multiple Sclerosis and Related Disorders10 citationsDOI

Topics & Concepts

Multiple sclerosisAlemtuzumabMedicineRelapsing remittingNatalizumabPediatricsPsychiatryInternal medicineTransplantationMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersMultiple Myeloma Research and Treatments
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina | Litcius